@article{dd96dcd4cc0542d9bc1f9a81abb3d30d,
title = "MAGNIFY: Phase IIIb Randomized Study of Lenalidomide Plus Rituximab (R2) Followed By Lenalidomide Vs. Rituximab Maintenance in Subjects with Relapsed/Refractory Follicular, Marginal Zone, or Mantle Cell Lymphoma",
author = "Andorsky, \{David J.\} and Abdulraheem Yacoub and Bitran, \{Jacob D.\} and Jason Melear and Brooks, \{Heather D.\} and Foon, \{Kenneth A.\} and Syed Rizvi and Mary Llorente and Jiahui Li and Sharman, \{Jeff P.\}",
note = "623. Mantle Cell, Follicular, and Other Indolent B-Cell Lymphoma-Clinical Studies: Poster I | David J. Andorsky, Abdulraheem Yacoub, Jacob D. Bitran, Jason Melear, Heather D. Brooks, Kenneth A. Foon, Syed Rizvi, Mary Llorente, Jiahui Li, Jeff P. Sharman; MAGNIFY: Phase IIIb Randomized Study of Lenalidomide Plus Rituximab (R 2) Followed By Lenalidomide Vs.",
year = "2016",
month = dec,
day = "2",
doi = "10.1182/BLOOD.V128.22.1798.1798",
language = "American English",
volume = "128",
journal = "Blood",
publisher = "American Society of Hematology",
number = "22",
}